Eli Lilly (LLY)

$363.95 1.82 (0.50%)

19:00 EST LLY Stock Quote Delayed 30 Minutes

7 Beaten-Down Stocks That Can Make You a Millionaire by 2030

By Joel Baglole, InvestorPlace Contributor Nov 28, 2022

Bet on the share prices of these leading companies to rebound and move higher in coming months as markets reverse higher.

3 Reasons to Turn Any LLY Stock Skeptic Into a Believer

Why Are Healthcare Stocks Down Today?

The 7 Best Pharma Stocks to Buy Now

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 2.21M

Day's Range $360.64 - $366.11

52-Week Range $231.87 - $369.80

Dividend & Yield $3.40 (0.93%)

LLY Stock Predictions, Articles, and Eli Lilly News

From InvestorPlace
From the Web

Why Is Akouos (AKUS) Stock Up 85% Today?

By David Moadel, InvestorPlace Contributor Oct 18, 2022

As a pharmaceutical giant seeks to delve deeper into gene therapy, today's merger announcement has AKUS stock traders in a frenzy.

These 7 Biotech Stocks Are Set to Boom in 2023

By Chris Markoch, InvestorPlace Contributor Oct 10, 2022

This article looks at seven biotech stocks that look like good options to move significantly higher in 2023

7 Growth Stocks to Buy to Tap Into a Hidden Bull Market

By Larry Ramer, InvestorPlace Contributor Sep 28, 2022

It's become a bit easier for investors to find growth stocks to buy hidden amid the bear market.

Biotech Stocks LLY, ESALY Gain on Biogen’s Positive Trial Results

By Josh Enomoto, InvestorPlace Contributor Sep 28, 2022

Biogen produced an outstanding Phase 3 result for its Alzheimer’s treatment, sending associated biotech stocks soaring.

7 Stocks to Buy That Can Soar in Good Times or in Bad

By Larry Ramer, InvestorPlace Contributor Sep 22, 2022

Investors looking for growth stocks to buy that are largely immune from broader economic woes have come to the right place.

3 Stocks That Could Rocket on Biden’s Cancer Moonshot

By Will Ashworth, InvestorPlace Contributor Sep 20, 2022

Joe Biden’s cancer moonshot gave some of the drug companies a big shot in the arm. These three stocks all are doing big things in oncology.

7 Blue-Chip Stocks to Buy for Safety in This Volatile Market

By Will Ashworth, InvestorPlace Contributor Sep 17, 2022

Market volatility has investors looking for blue-chip stocks to buy for safety. These seven ought to be at the top of your list.

Biotech Stocks Stand to Benefit as Biden Announces Support for Industry

By Samuel O'Brient, InvestorPlace Financial News Writer Sep 12, 2022

President Biden has announced a new initiative to help U.S. biotech producers grow. Here's what this news means for biotech stocks.

7 Best Pharmaceutical Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor Jul 20, 2022

These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.

5 S&P 500 Stocks Ready to Break Out

By Tyler Craig, Tales of a Technician Jun 29, 2022

Although Wall Street is hurting right now, not all S&P 500 stocks are getting thrashed. And these beauties are getting ready to break out.

7 Defensive Stocks to Buy for a Bear Market

By Tezcan Gecgil, InvestorPlace Contributor Jun 27, 2022

As Wall Street gets ready for another earnings season, investors are increasingly chasing after defensive stocks to buy for a bear market.

7 Defensive Stocks to Buy for a Bear Market

By Tezcan Gecgil, InvestorPlace Contributor Jun 27, 2022

As Wall Street gets ready for another earnings season, investors are increasingly chasing after defensive stocks to buy for a bear market.

4 Stocks Reporting Earnings the Week of April 4

By Joel Baglole, InvestorPlace Contributor Apr 1, 2022

Q4 2021 earnings season officially wraps up next week, but there are still a few companies left to report their financial results.

5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet

By Samuel O'Brient, InvestorPlace Financial News Writer Feb 4, 2022

Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech stocks to buy that can benefit.

7 of the Top-Rated Pharmaceutical Stocks for Q1

By Louis Navellier and the InvestorPlace Research Staff Jan 18, 2022

As the market begins to shift from high-growth, tech-fueled start-ups, one good long-term growth option is quality pharmaceutical stocks.

The 10 Best Performing Stocks in the S&P 500 for 2021

By Tezcan Gecgil, InvestorPlace Contributor Jan 12, 2022

Here're seven of the best performing stocks that saw record gains in the past 12 months

7 Pharmaceutical Stocks That Could Make You Rich

By Tezcan Gecgil, InvestorPlace Contributor Jan 6, 2022

These seven pharmaceutical stocks could create lucrative opportunities in the new year

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Dec 14, 2021

Good morning, trader! It's time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday!

7 Biotech Stocks Entering the Golden Boom Phase

By Chris Lau, InvestorPlace Contributor Sep 28, 2021

These biotech stocks offer a more mature take on an otherwise risky sector. These companies already have successes under their belt.

4 Top Stock Trades for Wednesday: Ethereum, Bitcoin, LLY, HOOD

By Bret Kenwell, InvestorPlace Contributor Aug 3, 2021

Ethereum, Bitcoin, Eli Lilly and Robinhood were our top stock trades for Wednesday. Now, let's look at the charts after some nice movement.

Eli Lilly (LLY)

7 Beaten-Down Stocks That Can Make You a Millionaire by 2030

3 Reasons to Turn Any LLY Stock Skeptic Into a Believer

Why Are Healthcare Stocks Down Today?

The 7 Best Pharma Stocks to Buy Now

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Eli Lilly (LLY)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

LLY Stock Predictions, Articles, and Eli Lilly News

Subscriber Sign in